1. Articles in category: Other Business News

    1-24 of 1308 1 2 3 4 ... 53 54 55 »
    1. Avinger Announces $7.6 Million Registered Direct Offering

      Avinger Announces $7.6 Million Registered Direct Offering

      Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale in a registered direct offering of an aggregate of 7,600 shares of Series D convertible preferred stock (the "Preferred Stock") and warrants to purchase up to an aggregate of 16,150,000 shares of common stock for gross proceeds of $7.6 million. The shares of Preferred Stock will have a ...

      Read Full Article
      Mentions: Avinger
    2. PhotoniCare Announces ISO 13485:2016 Certification

      PhotoniCare Announces ISO 13485:2016 Certification

      PhotoniCare, Inc.—a company revolutionizing frontline care with the OtoSight Middle Ear Scope that uses OCT technology to increase the objective accuracy of fluid assessment in the middle ear—announced that they have successfully completed their ISO 13485:2016 certification today. ISO 13485:2016 is an internationally recognized quality standard that specifies requirements for a quality management system used by an organization demonstrating its ability to provide medical devices and related services that consistently meet strict regulatory and customer requirements. The Quality Management System PhotoniCare utilizes to design, manufacture, and service OtoSight Middle Ear Scopes has officially been audited and ...

      Read Full Article
    3. Perimeter Medical Imaging AI Announces First Commercial Installation of Perimeter S-Series OCT in North Texas and Ongoing Market Development Activities Across the U.S.

      Perimeter Medical Imaging AI Announces First Commercial Installation of Perimeter S-Series OCT in North Texas and Ongoing Market Development Activities Across the U.S.

      Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced the first commercial installation of its flagship Perimeter S-Series OCT system at a North Texas hospital. Perimeter S-Series is a novel medical imaging system that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization (1-2 mm below the surface) of an excised tissue specimen across a variety of tissue types. Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “We are extremely pleased to announce the first commercial installation ...

      Read Full Article
    4. Conavi Medical Enters into Funding Agreements for Over $20 Million to Support Commercialization of its Innovative Intravascular Image Guidance Technology

      Conavi Medical Enters into Funding Agreements for Over $20 Million to Support Commercialization of its Innovative Intravascular Image Guidance Technology

      Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, has entered into agreements for over $20 million in funding to support commercialization and growth as it prepares its innovative Novasight Hybrid® System for market. The company aims to raise an additional $10 million as part of an ongoing financing effort. Conavi Medical is leading the way with its Novasight Hybrid System as a new imaging platform for use by interventional cardiologists during common minimally invasive heart procedures. This patented technology is the first and only clinical system that enables simultaneous and ...

      Read Full Article
    5. Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee

      Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee

      Perimeter Medical Imaging AI, Inc., a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced the initiation of a multi-center, randomized, two-arm pivotal clinical trial to evaluate its Perimeter B-Series OCT with ImgAssist AI for use during breast conservation surgery. The first patient procedures were performed by Richard E. Fine, MD and Michael Berry, MD, leading breast surgeons based out of the Margaret West Comprehensive Breast Center in Germantown, Tennessee. Dr. Richard E. Fine, Director of Education & Research, Margaret West Comprehensive Breast Center, West Cancer Center & Research Institute ...

      Read Full Article
    6. Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee

      Perimeter Medical Imaging AI Announces Initiation of First Clinical Trial Site at West Cancer Center & Research Institute in Tennessee

      Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced the initiation of a multi-center, randomized, two-arm pivotal clinical trial to evaluate its Perimeter B-Series OCT with ImgAssist AI for use during breast conservation surgery. The first patient procedures were performed by Richard E. Fine, MD and Michael Berry, MD, leading breast surgeons based out of the Margaret West Comprehensive Breast Center in Germantown, Tennessee. Dr. Richard E. Fine, Director of Education & Research ...

      Read Full Article
    7. Perimeter Medical Imaging AI Announces Strategic Private Placement to Social Capital (C$43.4 million)

      Perimeter Medical Imaging AI Announces Strategic Private Placement to Social Capital (C$43.4 million)

      Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that it has entered into a subscription agreement pursuant to which an affiliate of Social Capital Holdings Inc. (“Social Capital”) will make a strategic C$43.4 million investment in the Company. Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “We believe Social Capital’s investment marks a transformative, pivotal event for Perimeter that will help accelerate our growth. This strategic partnering ...

      Read Full Article
    8. Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome® AMD Home Monitoring Tests

      Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome® AMD Home Monitoring Tests

      The Notal Vision Monitoring Center celebrates the artificial intelligence (AI) based analysis of the ten millionth test performed by over 20,000 patients with the FDA-cleared ForeseeHome device. The device is part of a comprehensive remote monitoring service for intermediate age-related macular degeneration (AMD) patients at risk of developing the sight threatening wet form of the disease. The service monitors patients between office eye exams, when it’s difficult to manage the acute onset of wet disease that requires timely treatment. A recent large scale data analysis showed that the use of ForeseeHome provided a significant benefit to patients by ...

      Read Full Article
      Mentions: Notal Vision
    9. Perimeter Medical Imaging AI Reports Third Quarter 2021 Financial Results and Provides Corporate Update

      Perimeter Medical Imaging AI Reports Third Quarter 2021 Financial Results and Provides Corporate Update

      The net loss for the three months ended September 30, 2021 was $3,880,172 compared to the net income of $800,030 for the three months ended September 30, 2020. For the nine months ended September 30, 2021, cash used in operating activities was $10,032,107. As of September 30, 2021, cash and cash equivalents were $7,775,195 and investments were $794,000

      Read Full Article
    10. Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally

      Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally

      The newly formed company, Phoenix-Micron, Inc ., announced today it has completed the spin-out of the Phoenix MICRON® imaging platform from Phoenix Technology Group. This move is designed to increase focus and innovation in products designed to serve the eye and eye-brain research community. The new company, Phoenix-Micron, Inc. will be led by former Phoenix Technology Group CEO, Scott Carr, who served that role since 2018. Bringing Phoenix MICRON knowledge, and experience with imaging products for researchers, the team at Phoenix-Micron includes core R&D, engineering, sales, product, and manufacturing team members from Phoenix Technology Group. The leading in-vivo retinal imaging ...

      Read Full Article
    11. Peer-to-peer technology is very useful for developers of SS-OCT systems

      Peer-to-peer technology is very useful for developers of SS-OCT systems

      Peer-to-peer streaming is a crucial feature for data acquisition boards used in swept-source OCT (SS-OCT). Learn more about the underlying technology that helps achieve high-speed data transfers at 7 Gbyte/s to graphical processing units (GPUs), and helps significantly improve digitizer system's performance. P2P streaming side-tracks the host PC by enabling direct data transfers between the digitizer and graphics processing units (GPUs) or to storage. This is a huge advantage compared to conventional solutions which require data to be copied via the RAM of the host PC. With peer-to-peer, both the CPU and RAM can instead be used for ...

      Read Full Article
    12. Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

      Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

      Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for a new clinical indication for the Pantheris image-guided atherectomy system. This clearance allows the company to directly market Pantheris for the treatment of in-stent restenosis (ISR) in the lower extremity arteries. "We are excited to receive FDA clearance for the ISR indication, which expands our addressable market for Pantheris to include a high-incidence disease state ...

      Read Full Article
    13. Perimeter Medical Imaging AI Announces Important Milestone in Atlas Ai Project With FDA Investigational Device Exemption (IDE) Approval to Launch Clinical Trial Using Perimeter B-Series OCT With ImgAssist AI in Breast Conservation Surgery

      Perimeter Medical Imaging AI Announces Important Milestone in Atlas Ai Project With FDA Investigational Device Exemption (IDE) Approval to Launch Clinical Trial Using Perimeter B-Series OCT With ImgAssist AI in Breast Conservation Surgery

      erimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced approval of its Investigational Device Exemption (“IDE”) application by the U.S. Food and Drug Administration (“FDA”) to conduct a multi-center, randomized, double-arm study to evaluate the FDA breakthrough-device-designated Perimeter B-Series OCT imaging system that uses ImgAssist AI technology to identify regions of interest as compared with the current standard of care for patients undergoing breast conservation surgery. It is anticipated that ...

      Read Full Article
    14. MicroPort® Invests ~$58M for 51% of IV-OCT Imaging Start-up Argus

      MicroPort® Invests ~$58M for 51% of IV-OCT Imaging Start-up Argus

      MicroPort Scientific Corporation (00853.HK, “MicroPort ® ”) signed a strategic investment agreement with Suzhou Argus Medical Technology Co., (“Argus”) and the related parties. Under the agreement, MicroPort ® will directly invest in Argus and acquire part of the equity from the existing shareholders, with total cost of RMB 372.3 million. After completion of the transaction, MicroPort ® will become the controlling shareholder of Argus, with 51% equity interest in Argus. Founded in Suzhou Industrial Park in 2016, Argus focuses on solutions for intravascular OCT systems, and has successfully developed ArgusClarity™ OCT system and Argus NOPURGE TM purge-free disposable imaging catheter independently. ArgusClarity ...

      Read Full Article
    15. Enablence Technologies : Announces Financial Results for Fiscal Year 2021

      Enablence Technologies : Announces Financial Results for Fiscal Year 2021

      Enablence Technologies Inc. ("Enablence" or the "Company") (TSXV: ENA), a supplier of optical components and subsystems, has filed its audited financial statements for the fiscal year ending June 30, 2021 ("Fiscal Year 2021") and related management's discussion and analysis and certifications (collectively, the "Financial Statements"). Electronic copies of the Financial Statements are available on SEDAR (www.sedar.com) under Enablence's issuer profile

      Read Full Article
    16. Welcoming Gentuity® to the Nipro Vascular Portfolio

      Welcoming Gentuity® to the Nipro Vascular Portfolio

      Nipro Medical Corporation is proud to announce a commercial partnership in the United States with Gentuity LLC . Gentuity, an imaging technology firm founded in Massachusetts in 2015, is dedicated to developing next-generation intravascular devices that capitalize on today’s best-in-class technologies. With a proprietary platform fully incorporating the company’s AI tools to enhance ease of use and procedural success, Gentuity is transforming the world of intravascular imaging. Together with Gentuity, Nipro is excited to continue advancing patient care, improving outcomes, and delivering more value to healthcare providers. EXPERIENCE THE NEXT GENERATION OF OCT Nipro is excited to now offer ...

      Read Full Article
      Mentions: Gentuity
    17. Notal Vision Reports Results from First U.S. Home OCT Feasibility Study

      Notal Vision Reports Results from First U.S. Home OCT Feasibility Study

      Notal Vision, Inc. reported today that results of the first U.S.-based feasibility study with its investigational home-based optical coherence tomography (OCT) platform were presented at the Retina Society and the American Society of Retina Specialists (ASRS) annual meetings. The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet age-related macular degeneration (AMD), complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. The study evaluated the ability of subjects with wet AMD to perform sequential daily self-imaging of their ...

      Read Full Article
      Mentions: Notal Vision
    18. New Ultra-fast Digitizers gets a boost with peer-to-peer streaming

      New Ultra-fast Digitizers gets a boost with peer-to-peer streaming

      Anyone working in experimental science or with high-end sampling applications at the limits of modern ultra-fast digitizers will soon realize the performance benefits to be gained from peer-to-peer (P2P) streaming. Rather than data being arbitrated between the host and its local memory, P2P streaming side-tracks the host enabling direct data transfers between expansion cards in modern PC backplanes. In this white paper, we explore the pitfalls of PCIe data transfer – how maximum throughput is impacted by host architecture, protocol coding, and payload size. 

      Read Full Article
    19. Luneau Technology Group merges with Optovue

      Luneau Technology Group merges with Optovue

      Luneau Technology Group announced that its merger with Optovue Inc. will enable the two companies to offer a comprehensive portfolio of health solutions to eye care providers. “We’re two agile companies with a startup mentality of innovation and flexibility,” Marc Abitbol, PhD, CEO of the newly merged company, said in a press release. “Together, we now have a full pipeline that covers everything for visual health. Optovue’s OCT expertise, stellar reputation and primary position in the medical eye care market and complementary portfolio of products make us an ideal partner, so our combined company can offer complete end-to-end ...

      Read Full Article
      Mentions: Optovue
    20. Next Generation ASC Laser Controller Solution Is Now Available

      Next Generation ASC Laser Controller Solution Is Now Available

      ARGES, a product brand of Novanta Corporation (“Novanta”), announces the addition of its new laser controller, ASC Generation 4 to its ASC series portfolio. This new controller features powerful performance thanks to updated electronics, changeable multi-functional interface boards for added flexibility, and open platform with embedded Linux OS. This controller solution is compatible with all ARGES scan heads, lasers, and sub-systems. Packed with enhanced features and performance, this next generation controller works seamlessly with our proprietary software, InScript for a complete laser control solution. Our cross-collaborative team has worked tirelessly to develop a controller platform that enables a new level ...

      Read Full Article
    21. PHC Corporation of North America and SCREEN Partner to Promote 3D Live Cell Imaging in North America

      PHC Corporation of North America and SCREEN Partner to Promote 3D Live Cell Imaging in North America

      PHC Corporation of North America (PHCNA) and SCREEN Holdings Co., Ltd. have today announced the formation of a partnership to market and sell the SCREEN Cell3iMager series of live-cell imaging systems in North America. These innovative ex vivo imaging instruments enable organoid and spheroid imaging with excellent accuracy using high-throughput, high-speed, and non-invasive technology for cellular research, drug discovery, cosmetic and biopharmaceutical applications. SCREEN’s instrument portfolio includes high speed bright-field spheroid imagers, multi-fluorescence imaging in 2D and 3D, as well as live-cell imaging by optical coherence tomography (OCT). The instruments will be available alongside PHCbi’s current portfolio of ...

      Read Full Article
    22. Wasatch Photonics announces the appointment of Neil Anderson as Vice President, Gratings and OCT

      Wasatch Photonics announces the appointment of Neil Anderson as Vice President, Gratings and OCT

      Wasatch Photonics is pleased to announce and welcome Neil Anderson, Ph.D. as the new Vice President of Gratings and OCT. In this role, Neil will be responsible for commercial leadership and growth of the company’s transmission gratings and optical coherence tomography business, working with the teams in Logan, UT, and Morrisville, NC, to develop innovative product solutions matched to current and emerging market needs in laser pulse compression, optical coherence tomography (OCT), astronomy, and photonics. Neil is a well-known and respected figure in the optics and photonics industry and brings 15 years of experience supporting customers with optical ...

      Read Full Article
    23. Perimeter Medical Imaging AI Reports Second Quarter 2021 Financial Results and Provides ...

      Perimeter Medical Imaging AI Reports Second Quarter 2021 Financial Results and Provides ...

      Summary of Second Quarter 2021 Financial Results: All of the amounts are expressed in Canadian dollars unless otherwise indicated and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) applicable to the preparation of interim financial statements, including International Accounting Standard (“IAS”) 34, Interim Financial Reporting. Operating expenses for the three months ended June 30, 2021 were $3,056,431 compared to $1,997,959 during the same period in 2020. The net loss for the three months ended June 30, 2021 of $3,238,722 compared to $4,659,480 ...

      Read Full Article
    1-24 of 1308 1 2 3 4 ... 53 54 55 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (1 articles) Avinger